Single-nucleus profiling of postmortem diffuse midline gliomas identifies mitochondrial biogenesis as a resistance mechanism to imipridone therapy
Masahiro Okada, Bavani Subramaniam, Baobao Geng, Jangham Jung, Bohyeon Yu, Felicia Lin, Yu Fu, Yishu Wang, Weiqiang Yu, Sandra Laternser, Nalin Gupta, Sabine Müller, Lin Wang, Aaron Diaz, Javad Nazarian · 2026
Read Single-nucleus profiling of postmortem diffuse midline gliomas identifies mitochondrial biogenesis as a resistance mechanism to imipridone therapy by Masahiro Okada, Bavani Subramaniam, Baobao Geng, Jangham Jung, Bohyeon Yu, Felicia Lin, Yu Fu, Yishu Wang, Weiqiang Yu, Sandra Laternser, Nalin Gupta, Sabine Müller, Lin Wang, Aaron Diaz, Javad Nazarian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13550678.txt.
Description
Masahiro Okada and co-authors studied brain tumors from children who had died of a rare, harsh form in a 2026 paper. A new drug helps some of these patients, but many tumors learn to resist it. The team asked what sets the resistant tumors apart.
They read single cells from tumor samples kept after death and built a map of cell types and states. Tumors that fought the drug had more of the cell parts that make energy, and made them at a higher rate. Blocking that build-up made lab tumor cells respond to the drug again. The work names a clear next target to pair with the drug.
Catalog record
| CREATOR | Masahiro Okada, Bavani Subramaniam, Baobao Geng, Jangham Jung, Bohyeon Yu, Felicia Lin, Yu Fu, Yishu Wang, Weiqiang Yu, Sandra Laternser, Nalin Gupta, Sabine Müller, Lin Wang, Aaron Diaz, Javad Nazarian |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |